Dr Reddy's set for US generic Allegra D24 launch, seeks OTC switch
This article was originally published in Scrip
Executive Summary
A US district court has lifted a previous motion for injunction against Dr Reddy's Laboratories' generic version of Sanofi-Aventis' anti-allergic, Allegra D24 (fexofenadine HCl/pseudoephedrine HCl 180mg/240mg extended release tablets), paving the way for a launch of the product there.